Canada EpiPen shortage unacceptable, say NDP, Tories

02:16  02 august  2018
02:16  02 august  2018 Source:   msn.com

Pharmacies expected to run out of EpiPens in coming weeks: Health Canada

  Pharmacies expected to run out of EpiPens in coming weeks: Health Canada Pharmacies expected to run out of EpiPens in coming weeks: Health CanadaPfizer Canada has been reporting shortages for months due to manufacturing delays , and today told Health Canada it won't have new stock of the 0.3 mg adult dose of epinephrine until the end of August.

The Food and Drug Administration added EpiPen 0.3 mg and EpiPen Jr 0.15 mg Auto-Injectors as well as generic versions of these products to its drug shortages list.

The Food and Drug Administration has declared a shortage of EpiPen and EpiPen Jr. across major swaths of the country. Pfizer, whose subsidiary manufactures the EpiPen , said in a statement that "[t]he constrained supply of EpiPen is due to supply of certain third- party components, along with

a close up of a book © Provided by thecanadianpress.com OTTAWA - The federal opposition parties called on the Trudeau government Wednesday to urgently address the shortage of life-saving epinephrine auto-injectors, known as EpiPens.

But the Conservatives and New Democrats differ as to how to ensure an adequate supply.

The NDP says the Liberals must take all steps necessary to prevent a future supply crunch, even if it means threatening the drug maker with the loss of its patent on the device.

The Conservatives, on the other hand, recommended the government encourage development of a Canadian-based supply chain.

Shouting match derails debate at Ontario legislature; NDP MP accused of mocking Tory legislator's accent

  Shouting match derails debate at Ontario legislature; NDP MP accused of mocking Tory legislator's accent Debate over the Ontario government's proposal to slash Toronto city council by 22 seats months before a municipal election was derailed today as tensions between the Progressive Conservatives and the Opposition NDP reached a boiling point. A shouting match broke out between Premier Doug Ford and NDP Leader Andrea Horwath over allegations that one of her caucus members had made inappropriate comments towards a Tory legislator, prompting the Speaker to recess the legislature.The Tories allege NDP House Leader Gilles Bisson mocked the accent of Tory legislator Kaleed Rasheed, an accusation Bisson vehemently denies.

The FDA says manufacturing delays are behind what it expects to be a short-term shortage . FDA confirms EpiPen shortage - Продолжительность: 0:53 USA TODAY 483 просмотра.

TORONTO (Reuters) - Canada said on Tuesday it is working with the U.S. Food and Drug Administration to access supplies of Mylan N.V.’s EpiPen emergency allergy antidote amid a growing shortage that has spared the United States.

Drug giant Pfizer said this week that the EpiPens it produces are in short supply, with the potential that adult doses may not be available at all in August, a peak month for people who rely on the injectors to treat serious allergic reactions.

"Many Canadians rely on EpiPens as life-saving devices," said NDP health critic Don Davies.

"The minister of health should never have allowed this dangerous situation to develop, and now it's on her to fix this immediately."

The government said it was doing everything in its power to resolve the shortage as soon as possible, and advised Canadians with allergies to keep expired products.

"We continue to work closely with Pfizer Canada," said Thierry Belair, a spokesman for Health Minister Ginette Petitpas Taylor.

EpiPen shortage a growing concern for experts

  EpiPen shortage a growing concern for experts Repeated shortages of the life-saving EpiPen has "moved from an inconvenience to a concern," says Food Allergy Canada.The national advocacy group was among those alarmed by yet another announcement from Pfizer that its epinephrine auto-injector is in short supply, with executive director Jennifer Gerdts saying the latest shortfall comes just when it's needed most.

Despite reports of EpiPen shortages across the United States, one of the companies that manufactures the device said it is shipping the product.

The new MSN, Your customizable collection of the best in news, sports, entertainment, money, weather, travel, health, and lifestyle, combined with Outlook, Facebook, Twitter, Skype, and more. The FDA added EpiPen to its list of drug shortages , citing manufacturing issues.

Government officials noted that four other companies — Kaleo Pharma, Taro Pharmaceuticals, Valeant Canada and Lincoln Medical — have been approved to sell their epinephrine auto-injector products in Canada, but that Health Canada can't compel a private company to market and supply product.

Critics warn the shortages could continue to happen because there is no firm requirement that manufacturers provide a consistent supply.

Hematologist and medical historian Jacalyn Duffin thinks the government should designate a list of "essential" medicines and also foster a homegrown manufacturing industry, particularly since most drugs sold in Canada are made elsewhere.

EpiPens are just one of dozens of medications in short supply, said Duffin, who tracks drug shortages on her website, CanadianDrugShortage.com.

U.S.-based Pfizer produces EpiPens at a facility near St. Louis, Missouri, and there are no alternatives sold in Canada.

Jet fuel shortage in Norman Wells disrupts flights in the Sahtu

  Jet fuel shortage in Norman Wells disrupts flights in the Sahtu Imperial Oil, the only fuel supplier for Norman Wells, says a recent shipment of fuel wasn't usable for commercial flights. The airline's jet fuel supplier is Imperial Oil — the only such supplier in Norman Wells, N.W.T.

The spot shortages don’t mean people cannot get EpiPens or generics, but they may have to look harder or turn to a different brand. An FDA spokesperson said the shortage is expected to be "short-term."

(CNN) - Despite reports of EpiPen shortages across the United States, one of the companies that manufactures the device said it is shipping the product -- "though supplies may vary from pharmacy to pharmacy." EpiPen and EpiPen Jr

Health Canada said anyone who has an anaphylactic reaction but has only an expired EpiPen should use the expired product and immediately call 911.

Davies called that response to the shortage "unacceptable.

"Health Canada must ensure that they are always available in sufficient supply. People’s health and their lives are on the line."

The New Democrats called on the agency to make it a requirement for patent holders to supply the drug or lose their authorization to sell into the Canadian market.

"When foreign drug companies fail to supply Canadians with life-saving pharmaceuticals, the federal government can and must take action, including expropriating patents if necessary," said Davies.

But such an approach would lead to an even more critical shortage, or no supply at all, said Conservative health critic Marilyn Gladu, who noted there have been significant supply crunches for EpiPens in Canada three times in the past 12 months.

"That would put us in an even worse position," said Gladu.

Instead, the Trudeau government needs to set the conditions necessary to encourage Pfizer or other drug makers to set up production facilities in Canada, she said.

Pfizer also announced in April that it was running out of EpiPens, blaming the shortage on manufacturing delays. The shortage was felt at that time in the United Kingdom, but not the United States.

Gladu said pricing may be a factor driving Pfizer's product distributors in determining where scarce supplies should be shipped.

EpiPens can cost around $300 in the U.S., although drug chains including CVS sell generic versions for less, while in Canada they are priced at around $100. They are sold for even less in the U.K.

Ontario faces psychiatrist shortage: report .
TORONTO - A new report urges the Ontario government to offer incentives to psychiatrists in order to make up for a shortage it says is contributing to a growing mental health crisis across the province and the country. The report, released Wednesday by the Coalition of Ontario Psychiatrists, says the province should also increase the number of psychiatry residency spots available to medical students and increase exposure to the field in medical school to six weeks.

—   Share news in the SOC. Networks
This is interesting!